Kazuya Sakai, Tatsuhiko Someya, Kaori Harada, Hideo Yagi, Taei Matsui, and Masanori Matsumoto. 2019. “Novel Aptamer to Von Willebrand Factor A1 Domain (TAGX-0004) Shows Total Inhibition of Thrombus Formation Superior to ARC1779 and Comparable to Caplacizumab”. Haematologica 105 (11). Pavia, Italy, 2631-38. https://doi.org/10.3324/haematol.2019.235549.